Pneumococcal vaccine shows high efficacy rate

11/16/2012 | PhysiciansBriefing.com

A pediatric study of the pneumococcal vaccine PHiD-CV10 showed efficacy rates of 100% and 92% for the 3+1 and 2+1 vaccination schedules, respectively. "For the first time, effectiveness of a 2+1 schedule in infants was confirmed in a clinical trial," Finnish researchers reported in the journal The Lancet.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC